Cross-linking is a minimally invasive, FDA approved, outpatient procedure that combines the use of prescription eye drops, Photrexa Viscous(riboflavin5’-phosphate in 20% dextran ophthalmic solution), Photrexa (riboflavin 5’-phosphate ophthalmic solution), and ultra-violet A (UVA) light from the KXL system for the treatment of progressive keratoconus.